Purchase Order 75N98026P00461

This is a $199,847.40 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Becton, Dickinson and Company (BD) for the maintenance of FACSYMPHONY A5 instruments. The contract has an ultimate completion date of September 30, 2025. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research and clinical applications, including flow cytometry, cell imaging, and genomics...

Becton, Dickinson and Company's BD Biosciences division was awarded a $201,042 firm fixed-price purchase order by the National Heart Lung and Blood Institute (NHLBI) on April 1, 2025, for the Service Agreement Symphony A3 and Lasers. The contract, which operates without a small business set-aside, has an ultimate completion date of March 31, 2030, and will be performed in Bethesda, Maryland. Based on BD Biosciences' established federal contract portfolio, this award likely encompasses...

The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for $29,795.40 on January 23, 2019, for a maintenance agreement with an ultimate completion date of January 31, 2020. Work is performed at Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied. The maintenance agreement supports BD flow cytometry instrumentation operated by the Institute, consistent with BD Biosciences' established supplier...

This is a $17,118.00 firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) to provide a service contract to maintain a flow cytometer. The contract period of performance is June 2, 2025 through June 1, 2026. No set-aside designation was used for this award. BD is a global medical technology company that develops, manufactures, and sells medical devices,...

The National Heart, Lung, and Blood Institute (NHLBI) awarded a delivery order valued at $53,205.12 to Becton, Dickinson and Company (BD Biosciences) on January 1, 2026, for maintenance coverage of its LSRFortessa flow cytometry system and throughput sampler. This firm fixed-price contract, which serves as a child delivery order under a larger indefinite delivery vehicle, will be performed in San Jose, California and is scheduled for completion by December 31, 2026. The award was made without...

Becton, Dickinson and Company (BD) was awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Heart, Lung and Blood Institute to provide maintenance services for a BD Biosciences Fortessa flow cytometer. The potential value of this contract is $147,863.40. No set-aside designation was used for this award. Performance will occur in Bethesda, Maryland and continue through January 31, 2025. This award is associated with the...

The National Heart Lung and Blood Institute issued a $13,115.28 delivery order to Becton, Dickinson and Company (BD Biosciences) on December 20, 2017, with an ultimate completion date of November 17, 2018. This is a firm fixed-price delivery order placed under the GSA Scientific Equipment and Services Schedule (FSS-66). Place of performance is Bethesda, MD. The order was issued without a set-aside. BD Biosciences supplies flow cytometry systems, reagents, and related biomedical research...

<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) valued at $597,605.36 on September 10, 2018, for BD FACSymphony trade-in and purchase. The order has no small business set-aside. Performance is located in San Jose, California. The ultimate completion date is February 28, 2019. The originating opportunity was posted as a special notice on August 30, 2018.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for a maintenance agreement valued at $32,562.00, with an award date of February 28, 2019 and completion date of March 14, 2020. Place of performance is San Jose, California. The order is priced on a firm fixed price basis with no small business set-aside.</p>

The National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order valued at one hundred sixty-five thousand five hundred seventeen dollars and thirteen cents ($165,517.13) to Becton, Dickinson and Company for a BD FACSymphony A1 cell analyzer. Becton, Dickinson and Company will deliver the requested cell analyzer as the prime contractor. No set-aside designation was used for this award. Performance will occur at Sparks Glencoe, Maryland by...